A Semisynthetic Bioluminescence Sensor for Ratiometric Imaging of Metal Ions In Vivo Using DNAzymes Conjugated to An Engineered Nano-Luciferase.
Mengyi XiongYuting WuGezhi KongWhitney LewisZhenglin YangHanxiao ZhangLi XuYing LiuQin LiuXuhua ZhaoXiao-Bing ZhangYi LuPublished in: Angewandte Chemie (International ed. in English) (2023)
DNA-based probes have gained significant attention as versatile tools for biochemical analysis, benefiting from their programmability and biocompatibility. However, most existing DNA-based probes rely on fluorescence as the signal output, which can be problematic due to issues like autofluorescence and scattering when applied in complex biological materials such as living cells or tissues. Herein, we report the development of bioluminescent nucleic acid (bioLUNA) sensors that offer laser excitation-independent and ratiometric imaging of the target in vivo. The system is based on computational modelling and mutagenesis investigations of a genetic fusion between circular permutated Nano-luciferase (NLuc) and HaloTag, enabling the conjugation of the protein with a DNAzyme. In the presence of Zn 2+ , the DNAzyme sensor releases the fluorophore-labelled strand, leading to a reduction in bioluminescent resonance energy transfer (BRET) between the luciferase and fluorophore. Consequently, this process induces ratiometric changes in the bioluminescent signal. We demonstrated that this bioLUNA sensor enabled imaging of both exogenous Zn 2+ in vivo and endogenous Zn 2+ efflux in normal epithelial prostate and prostate tumors. This work expands the DNAzyme sensors to using bioluminescence and thus has enriched the toolbox of nucleic acid sensors for a broad range of biomedical applications.
Keyphrases
- living cells
- energy transfer
- fluorescent probe
- nucleic acid
- single molecule
- quantum dots
- high resolution
- prostate cancer
- heavy metals
- low cost
- benign prostatic hyperplasia
- genome wide
- working memory
- small molecule
- dna methylation
- sensitive detection
- photodynamic therapy
- nitric oxide
- high speed
- risk assessment
- tissue engineering
- water soluble